Neurologic Disorders Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: NDCCCCC4001BEN
Market Monitor Global

Abstracts

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.

This report contains market size and forecasts of Neurologic Disorders Therapeutics in Global, including the following market information:

Global Neurologic Disorders Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neurologic Disorders Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Central Nervous System (CNS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurologic Disorders Therapeutics include Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurologic Disorders Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurologic Disorders Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neurologic Disorders Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Central Nervous System (CNS)
• Peripheral Nervous System (PNS)

Global Neurologic Disorders Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neurologic Disorders Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Paralysis
• Muscle Weakness
• Poor Coordination
• Loss of Sensation
• Seizures
• Confusion
• Pain and Altered Levels of Consciousness

Global Neurologic Disorders Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neurologic Disorders Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neurologic Disorders Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neurologic Disorders Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen Inc.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Pfizer Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neurologic Disorders Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neurologic Disorders Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Neurologic Disorders Therapeutics Market Size: 2021 VS 2028
2.2 Global Neurologic Disorders Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neurologic Disorders Therapeutics Players in Global Market
3.2 Top Global Neurologic Disorders Therapeutics Companies Ranked by Revenue
3.3 Global Neurologic Disorders Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Neurologic Disorders Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neurologic Disorders Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurologic Disorders Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Neurologic Disorders Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neurologic Disorders Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neurologic Disorders Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Central Nervous System (CNS)
  4.1.3 Peripheral Nervous System (PNS)
4.2 By Type - Global Neurologic Disorders Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Neurologic Disorders Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Neurologic Disorders Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neurologic Disorders Therapeutics Market Size, 2021 & 2028
  5.1.2 Paralysis
  5.1.3 Muscle Weakness
  5.1.4 Poor Coordination
  5.1.5 Loss of Sensation
  5.1.6 Seizures
  5.1.7 Confusion
  5.1.8 Pain and Altered Levels of Consciousness
5.2 By Application - Global Neurologic Disorders Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Neurologic Disorders Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Neurologic Disorders Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neurologic Disorders Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Neurologic Disorders Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Neurologic Disorders Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Neurologic Disorders Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neurologic Disorders Therapeutics Revenue, 2017-2028
  6.3.2 US Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.3.3 Canada Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Neurologic Disorders Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neurologic Disorders Therapeutics Revenue, 2017-2028
  6.4.2 Germany Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.3 France Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.5 Italy Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.6 Russia Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Neurologic Disorders Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neurologic Disorders Therapeutics Revenue, 2017-2028
  6.5.2 China Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.5.3 Japan Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.5.6 India Neurologic Disorders Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neurologic Disorders Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Neurologic Disorders Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neurologic Disorders Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.7.3 Israel Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Neurologic Disorders Therapeutics Market Size, 2017-2028
  6.7.5 UAE Neurologic Disorders Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biogen Inc.
  7.1.1 Biogen Inc. Corporate Summary
  7.1.2 Biogen Inc. Business Overview
  7.1.3 Biogen Inc. Neurologic Disorders Therapeutics Major Product Offerings
  7.1.4 Biogen Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Biogen Inc. Key News
7.2 F. Hoffmann-La Roche Ltd.
  7.2.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd. Key News
7.3 Johnson & Johnson Services Inc.
  7.3.1 Johnson & Johnson Services Inc. Corporate Summary
  7.3.2 Johnson & Johnson Services Inc. Business Overview
  7.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Major Product Offerings
  7.3.4 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Services Inc. Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Neurologic Disorders Therapeutics Major Product Offerings
  7.4.4 Novartis AG Neurologic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Pfizer Inc.
  7.5.1 Pfizer Inc. Corporate Summary
  7.5.2 Pfizer Inc. Business Overview
  7.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Major Product Offerings
  7.5.4 Pfizer Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neurologic Disorders Therapeutics Market Opportunities & Trends in Global Market
Table 2. Neurologic Disorders Therapeutics Market Drivers in Global Market
Table 3. Neurologic Disorders Therapeutics Market Restraints in Global Market
Table 4. Key Players of Neurologic Disorders Therapeutics in Global Market
Table 5. Top Neurologic Disorders Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neurologic Disorders Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neurologic Disorders Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neurologic Disorders Therapeutics Product Type
Table 9. List of Global Tier 1 Neurologic Disorders Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurologic Disorders Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neurologic Disorders Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neurologic Disorders Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neurologic Disorders Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neurologic Disorders Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neurologic Disorders Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neurologic Disorders Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Inc. Corporate Summary
Table 31. Biogen Inc. Neurologic Disorders Therapeutics Product Offerings
Table 32. Biogen Inc. Neurologic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offerings
Table 35. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services Inc. Corporate Summary
Table 37. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offerings
Table 38. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Neurologic Disorders Therapeutics Product Offerings
Table 41. Novartis AG Neurologic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Neurologic Disorders Therapeutics Product Offerings
Table 44. Pfizer Inc. Neurologic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neurologic Disorders Therapeutics Segment by Type in 2021
Figure 2. Neurologic Disorders Therapeutics Segment by Application in 2021
Figure 3. Global Neurologic Disorders Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neurologic Disorders Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neurologic Disorders Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurologic Disorders Therapeutics Revenue in 2021
Figure 8. By Type - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neurologic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neurologic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Inc. Neurologic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Neurologic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Neurologic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)